## **Core Concept**
Invasive breast cancer encompasses various histologic types, each with distinct characteristics and prognoses. The most common types include invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), medullary carcinoma, tubular carcinoma, and mucinous carcinoma. The prognosis of these types varies based on factors such as tumor differentiation, receptor status, and growth patterns.

## **Why the Correct Answer is Right**
Tubular carcinoma is a subtype of invasive ductal carcinoma that is characterized by its well-differentiated cells and a relatively indolent course. It accounts for about 2% of all breast cancers and typically presents with a favorable prognosis due to its low grade, small size, and **luminal A receptor subtype** characteristics, which are often **estrogen receptor-positive (ER+) and progesterone receptor-positive (PR+)** but **HER2-negative**. These features contribute to its better prognosis compared to other types of invasive breast cancer.

## **Why Each Wrong Option is Incorrect**
- **Option A:** IDC (Invasive Ductal Carcinoma) not otherwise specified (NOS) has a more variable prognosis depending on its grade, receptor status, and other factors but generally does not have as favorable a prognosis as tubular carcinoma.
- **Option B:** ILC (Invasive Lobular Carcinoma) often presents with multifocal and bilateral disease, which can complicate treatment and potentially worsen the prognosis compared to tubular carcinoma.
- **Option C:** Medullary carcinoma, while having a relatively favorable prognosis due to its association with **triple-negative status** and often a high lymphocyte count indicating an immune response, generally does not have as good a prognosis as tubular carcinoma.
- **Option D:** Mucinous carcinoma, also known as colloid carcinoma, has a favorable prognosis due to its low grade and less aggressive nature but tends to have a slightly worse prognosis than tubular carcinoma.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that tubular carcinoma of the breast often expresses **estrogen and progesterone receptors**, making it responsive to hormonal therapy, which contributes to its favorable prognosis. Patients with this type of cancer may have a **5-year survival rate** that approaches that of ductal carcinoma in situ (DCIS), highlighting the importance of histological diagnosis in determining prognosis.

## **Correct Answer:** . Tubular carcinoma.